Jefferies analyst Brian Tanquilut downgraded Oak Street Health (OSH) to Hold from Buy with a price target of $39, up from $36, after CVS Health (CVS) announced a definitive agreement to acquire the company for $39 per share in an all-cash transaction. Given that a month has passed since the pending deal was first reported in the press, the analyst does not expect competing bids to emerge at this point.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on OSH:
- Oak Street Health downgraded to Market Perform from Outperform at William Blair
- Oak Street Health downgraded to Hold from Buy at Canaccord
- Oak Street Health downgraded to Hold from Buy at Truist
- CVS Health says Oak Street Health deal has long term growth, earnings power
- Oak Street Health downgraded to In Line from Outperform at Evercore ISI
